phenylbutazone has been researched along with ethyl biscoumacetate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coppi, G; Perego, R; Vanoni, PC; Vidi, A | 1 |
| Weiner, M | 1 |
| O'Reilly, RA | 1 |
| Burns, JJ | 1 |
| Cajzl, L; Cepelák, V; Chudácek, Z | 1 |
| Cepelák, V; Cepeláková, H; Nĕmecek, O; Roubal, Z | 1 |
| Cepelák, V; Cepeláková, H; Dlabac, A; Grimová, J; Roubal, Z | 1 |
| Duckert, F; Seiler, K | 1 |
| Bodin, G; Camguilhem, R; Galtier, P | 1 |
| SCHERMANN, S | 1 |
1 review(s) available for phenylbutazone and ethyl biscoumacetate
| Article | Year |
|---|---|
The pharmacodynamics of the oral anticoagulant drugs.
Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Factors; Blood Proteins; Clofibrate; Coumarins; Dicumarol; Disulfiram; Ethyl Biscoumacetate; Female; Heparin; Intestinal Absorption; Liver; Phenylbutazone; Protein Binding; Prothrombin; Prothrombin Time; Rabbits; Rats; Salicylates; Sulfonamides; Vitamin K; Vitamin K Deficiency; Warfarin | 1974 |
9 other study(ies) available for phenylbutazone and ethyl biscoumacetate
| Article | Year |
|---|---|
Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. Enzyme induction and interaction with other drugs in the rat.
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Barbiturates; Blood Glucose; Dicumarol; Drug Interactions; Enzyme Induction; Ethyl Biscoumacetate; Female; Hypoglycemic Agents; Phenylbutazone; Prothrombin Time; Pyrazoles; Rats; Terpenes; Time Factors; Tolbutamide | 1972 |
An immunologic approach to the understanding of the physiologic disposition.
Topics: Animals; Binding Sites; Blood Proteins; Dicumarol; Diffusion; Dogs; Enzyme Induction; Ethyl Biscoumacetate; Half-Life; Haplorhini; Horses; Humans; Immunochemistry; Kinetics; Macrophages; Organ Specificity; Oxyphenbutazone; Papio; Pharmaceutical Preparations; Phenylbutazone; Protein Binding; Rats; Solubility; Species Specificity; Time Factors | 1973 |
IV. Pharmacogenetics and drug toxicity. Variation of drug metabolism in animals and the prediction of drug action in man.
Topics: Animals; Antipyrine; Ascorbic Acid; Barbiturates; Carbon Isotopes; Cats; Chlordan; Dicumarol; Dogs; Environmental Exposure; Ethyl Biscoumacetate; Glucuronates; Guinea Pigs; Haplorhini; Horses; Humans; Meperidine; Oxyphenbutazone; Pharmaceutical Preparations; Phenobarbital; Phenols; Phenylbutazone; Rabbits; Species Specificity; Sulfates | 1968 |
Experience with phlebography in acute deep vein thrombosis and after its treatment.
Topics: Acute Disease; Anti-Inflammatory Agents; Diatrizoate; Drug Therapy, Combination; Ethyl Biscoumacetate; Femoral Vein; Fibrinolysis; Heparin; Humans; Iliac Vein; Injections, Intravenous; Middle Aged; Phenylbutazone; Phlebography; Streptokinase; Thrombophlebitis; Tibia; Time Factors | 1972 |
Chemical induction of fibrinolysis and inhibition of platelet aggregation (with special respect to effect of nonsteroid antiinflammatory drugs).
Topics: Acetates; Adenosine Diphosphate; Animals; Anti-Inflammatory Agents; Arteriosclerosis; Arthritis, Rheumatoid; Blood Coagulation; Collagen; Coumarins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ethyl Biscoumacetate; Fibrinolysis; Humans; In Vitro Techniques; Methods; Phenylbutazone; Platelet Adhesiveness; Pyrazoles; Rats; Thrombophlebitis; Warfarin | 1972 |
Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
Topics: Adenosine Diphosphate; Administration, Oral; Animals; Anti-Inflammatory Agents; Blood Coagulation; Blood Coagulation Tests; Coumarins; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Ethyl Biscoumacetate; In Vitro Techniques; Injections, Subcutaneous; Phenylbutazone; Platelet Adhesiveness; Prothrombin Time; Pyrazoles; Rabbits; Rats; Warfarin | 1972 |
Properties of 3-(1-phenyl-propyl)-4-oxycoumarin (marcoumar) in the plasma when tested in normal cases and under the influence of drugs.
Topics: Blood Proteins; Coumarins; Drug Synergism; Ethyl Biscoumacetate; Fluorometry; Phenobarbital; Phenylbutazone; Protein Binding; Spectrophotometry; Sulfadimethoxine; Sulfinpyrazone; Tolbutamide | 1968 |
Evidence for in vitro and in vivo interaction between ochratoxin A and three acidic drugs.
Topics: Animals; Binding, Competitive; Blood Proteins; Diet; Drug Interactions; Ethyl Biscoumacetate; In Vitro Techniques; Lethal Dose 50; Male; Ochratoxins; Phenylbutazone; Protein Binding; Rats; Sulfamethoxypyridazine | 1980 |
[PREVENTION OF THROMBOTIC COMPLICATIONS FOLLOWING GYNECOLOGICAL SURGERY].
Topics: Anticoagulants; Ethyl Biscoumacetate; Female; Gynecologic Surgical Procedures; Gynecology; Humans; Phenylbutazone; Postoperative Complications; Procaine; Thrombosis | 1963 |